Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

No phase data

Trial Status

Completed2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT05042232Completed
A Prospective Virtual Study of Patient Reported Behaviors and Health Outcomes in Individuals With COVID-19
SARS-CoV-2 Acute Respiratory Disease
PrincipalinvestigatorStart date: 2021-04-19
NCT05042193Completed
A Prospective Virtual Study to Evaluate the Longevity of IgG Antibodies in Individuals Exposed to COVID-19
SARS-CoV-2 Acute Respiratory Disease
PrincipalinvestigatorStart date: 2021-03-19

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Everly Health

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Ze Chen, master

Air Force Military Medical University, China

Moderately Similar
1 trials

Shared therapeutic areas:

SARS-CoV-2 Acute Respiratory Disease
Similarity Score30%

Julie Parsonnet, MD

Stanford University

Moderately Similar
6 trials

Shared therapeutic areas:

SARS-CoV-2 Acute Respiratory Disease
Similarity Score30%

Kejian Wu, doctor

Air Force Military Medical University, China

Moderately Similar
1 trials

Shared therapeutic areas:

SARS-CoV-2 Acute Respiratory Disease
Similarity Score30%

Sabine Hazan, MD

ProgenaBiome

Moderately Similar
41 trials

Shared therapeutic areas:

SARS-CoV-2 Acute Respiratory Disease
Similarity Score30%

Glenn Chertow, MD

Stanford University

Moderately Similar
4 trials

Shared therapeutic areas:

SARS-CoV-2 Acute Respiratory Disease
Similarity Score30%

Myrielle Dupont-Rouzeyrol, PhD

Institut Pasteur de Nouvelle-Calédonie

Moderately Similar
4 trials

Shared therapeutic areas:

SARS-CoV-2 Acute Respiratory Disease
Similarity Score30%

Valérie Albert-Dunais, MD

Centre Hospitalier Spécialisé de Nouvelle-Calédonie

Moderately Similar
1 trials

Shared therapeutic areas:

SARS-CoV-2 Acute Respiratory Disease
Similarity Score30%

Fanny BOUNES, MD

University Hospital, Toulouse

Moderately Similar
3 trials

Shared therapeutic areas:

SARS-CoV-2 Acute Respiratory Disease
Similarity Score30%

Kari AO Tikkinen, MD PhD

University of Helsinki

Moderately Similar
3 trials

Shared therapeutic areas:

SARS-CoV-2 Acute Respiratory Disease
Similarity Score30%

Kamyar M. Hedayat, MD

Numa Health International

Moderately Similar
1 trials

Shared therapeutic areas:

SARS-CoV-2 Acute Respiratory Disease
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT05042232PrincipalInvestigator

A Prospective Virtual Study of Patient Reported Behaviors and Health Outcomes in Individuals With COVID-19

SARS-CoV-2 Acute Respiratory Disease
Completed
NCT05042193PrincipalInvestigator

A Prospective Virtual Study to Evaluate the Longevity of IgG Antibodies in Individuals Exposed to COVID-19

SARS-CoV-2 Acute Respiratory Disease
Completed

All 2 trials loaded